Wednesday, December 14, 2016

New Noninvasive Alzheimer's Treatment

Recent studies conducted on mice, engineered to have Alzheimer's have revealed that light therapy greatly reduces the effects of the disease on the brain. Alzheimer's is an irreversible genetic condition that affects brain function (cognition and memory), and becomes worse over time. The brain becomes congested with beta-amyloid plaque, gamma oscillations become impaired, and begins to form abnormal tau proteins that form tangles in the brain.

Tests conducted at MIT treated diseased mice with light therapy, inducing gamma oscillations at 40 hertz for one hour, beta-amyloid levels dropped by 50%, the only drawback being that beta-amyloids fully recovered to previous levels within 24 hours of treatment. The light therapy also removes plaque and mutated tau proteins. This gamma oscillation also improves the brains overall ability to get rid of mutated or faulty proteins.

Beta-amyloid plaques

Overall I believe this finding is quite fascinating, and could possibly be a big breakthrough in science and the medical field. It is clearly stated that this study has only been done on mice, but everyone including myself has hopes the effect of light therapy will translate to human beings.

Image taken from http://cdn1.medicalnewstoday.com/content/images/articles/314/314627/beta-amyloid-plaques-between-nerve-cells.jpg

4 comments:

  1. Alzheimer's is such a sad and horrible disease,this is a very important experiment. I hope they can find a treatment that completely helps patients with this disease diagnosis.

    ReplyDelete
  2. It is amazing that a certain wavelength of light can help with the Alzheimer's let alone the brain. It will be cool to see if thise trail is every in the clinical stage. It would be nice if this insight could help cure or ease Alzheimer's

    ReplyDelete
  3. This new information can be of great use to people! Perhaps more research into light therapy could be beneficial for human Alzheimer treatment.

    ReplyDelete
  4. BIOTRIAL is recruiting for a study and you can help!
    Seeking participants interested in a clinical research study with an investigational medication for Alzheimer's disease.

    You must be:
    40-85 years of age.
    Non-smoker or ex-smoker.

    Refer a friend or family member who is diagnosed with Alzheimer's or amnestic mild cognitive impairment and you can earn a referral bonus of $200.

    For more details please visit: Study Scavenger Alzheimer's Disease Study

    #alzheimersdisease #dementia #newark #nj

    ReplyDelete